Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| LARIMAR THERAPEUTICS | 8 | 4 | -1,64 % | ||
| MEIRAGTX | 5 | - | +0,70 % | ||
| AQUESTIVE THERAPEUTICS | 4 | 2 | 0,00 % | ||
| SAREPTA THERAPEUTICS | 4 | 1 | +1,92 % | ||
| SCPHARMACEUTICALS | 4 | - | -2,92 % | ||
| REGENERON PHARMACEUTICALS | 3 | 22 | +1,34 % | ||
| MACROGENICS | 3 | 4 | -4,11 % | ||
| CODEXIS | 3 | 3 | +15,86 % | ||
| LEXEO THERAPEUTICS | 3 | 3 | 0,00 % | ||
| LIGAND PHARMACEUTICALS | 3 | 2 | +0,76 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:15 | Dividendenbekanntmachungen (15.08.2025) | 510 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALBEMARLE CORPORATION PREF A US0126532003 0,9062 USD 0,7778 EUR APPLIED INDUSTRIAL TECHNOLOGIES INC US03820C1053 0,46 USD 0,3948... ► Artikel lesen | |
| 08:43 | XFRA I5X: AUSSETZUNG/SUSPENSION | 142 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPRECIGEN INC. I5X... ► Artikel lesen | |
| 06:34 | Precigen: EPS verfehlt Schätzungen - Umsatz besser als erwartet | 17 | Investing.com Deutsch | ||
| 00:36 | Akero Therapeutics Inc.: Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH | 4 | GlobeNewswire (USA) | ||
| Do | Pyxis Oncology GAAP EPS of -$0.30 beats by $0.05, revenue of $2.8M | 1 | Seeking Alpha | ||
| Do | Annexon Biosciences GAAP EPS of -$0.34 beats by $0.03 | 2 | Seeking Alpha | ||
| Do | Omeros GAAP EPS of -$0.44 beats by $0.06 | 1 | Seeking Alpha | ||
| Do | MacroGenics GAAP EPS of -$0.57 misses by $0.10, revenue of $22.24M misses by $5.82M | 1 | Seeking Alpha | ||
| Do | MacroGenics Inc: EPS verfehlt Schätzungen um 0,11 $ - Umsatz schlechter als erwartet | 4 | Investing.com Deutsch | ||
| Do | Tevogen Bio Holdings Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Do | LIGAND PHARMACEUTICALS INC - 8-K, Current Report | 2 | SEC Filings | ||
| Do | Tyra Biosciences, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| Do | Ligand Pharmaceuticals: Ligand Announces Closing of Convertible Senior Notes Offering | 1 | GlobeNewswire (USA) | ||
| Do | Ligand Pharmaceuticals completes $460 million convertible notes offering | 1 | Investing.com | ||
| Do | OMEROS CORP - 8-K, Current Report | - | SEC Filings | ||
| Do | MacroGenics, Inc.: MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities | 7 | GlobeNewswire (USA) | ||
| Do | Tevogen Bio Inc: Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected | 1 | GlobeNewswire (USA) | ||
| Do | Larimar Therapeutics, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| Do | Larimar Therapeutics stock holds Buy rating at Truist ahead of September data | 4 | Investing.com | ||
| Do | Larimar Therapeutics: Truist bestätigt Kaufempfehlung vor wichtigen Studiendaten im September | 6 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .